CRIP3
geneOn this page
Also known as TLP-AbA480N24.2TLP
Summary
CRIP3 (cysteine rich protein 3, HGNC:17751) is a protein-coding gene on chromosome 6p21.1, encoding Cysteine-rich protein 3 (Q6Q6R5).
Predicted to enable metal ion binding activity. Predicted to act upstream of or within T cell proliferation. Predicted to be located in cytoplasm.
Source: NCBI Gene 401262 — RefSeq curated summary.
At a glance
- GWAS associations: 20
- Clinical variants (ClinVar): 37 total
- MANE Select transcript:
NM_206922
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:17751 |
| Approved symbol | CRIP3 |
| Name | cysteine rich protein 3 |
| Location | 6p21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TLP-A, bA480N24.2, TLP |
| Ensembl gene | ENSG00000146215 |
| Ensembl biotype | protein_coding |
| Entrez | 401262 |
Gene structure
Transcript identifiers
Ensembl transcripts: 21 — 18 protein_coding, 3 retained_intron
ENST00000274990, ENST00000372569, ENST00000416431, ENST00000451294, ENST00000477866, ENST00000485819, ENST00000487744, ENST00000875330, ENST00000875331, ENST00000875332, ENST00000875333, ENST00000917954, ENST00000917955, ENST00000917956, ENST00000917957, ENST00000917958, ENST00000917959, ENST00000917960, ENST00000917961, ENST00000917962, ENST00000917963
RefSeq mRNA: 2 — MANE Select: NM_206922
NM_001366068, NM_206922
CCDS: CCDS4894
Canonical transcript exons
ENST00000372569 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000974499 | 43308315 | 43308409 |
| ENSE00000974501 | 43307612 | 43307743 |
| ENSE00000974502 | 43306446 | 43306517 |
| ENSE00000974503 | 43306219 | 43306313 |
| ENSE00001458118 | 43305472 | 43305875 |
| ENSE00003545360 | 43307839 | 43307896 |
| ENSE00003570712 | 43306067 | 43306124 |
| ENSE00003902020 | 43308750 | 43308826 |
Expression profiles
Bgee: expression breadth ubiquitous, 165 present calls, max score 95.03.
FANTOM5 (CAGE): breadth broad, TPM avg 1.1956 / max 53.0668, expressed in 275 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 73675 | 1.0381 | 246 |
| 73676 | 0.1574 | 90 |
Top tissues by expression
241 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| apex of heart | UBERON:0002098 | 95.03 | gold quality |
| right testis | UBERON:0004534 | 92.37 | gold quality |
| left testis | UBERON:0004533 | 92.14 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 90.09 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 90.00 | gold quality |
| cerebellar cortex | UBERON:0002129 | 89.98 | gold quality |
| testis | UBERON:0000473 | 88.30 | gold quality |
| cerebellum | UBERON:0002037 | 88.29 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.70 | gold quality |
| right lobe of liver | UBERON:0001114 | 85.23 | gold quality |
| granulocyte | CL:0000094 | 85.16 | gold quality |
| heart left ventricle | UBERON:0002084 | 84.88 | gold quality |
| cardiac ventricle | UBERON:0002082 | 84.43 | gold quality |
| nucleus accumbens | UBERON:0001882 | 83.88 | gold quality |
| right frontal lobe | UBERON:0002810 | 81.96 | gold quality |
| putamen | UBERON:0001874 | 81.85 | gold quality |
| caudate nucleus | UBERON:0001873 | 81.47 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 81.34 | gold quality |
| amygdala | UBERON:0001876 | 81.14 | gold quality |
| spleen | UBERON:0002106 | 80.55 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 79.51 | gold quality |
| hypothalamus | UBERON:0001898 | 79.40 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 77.06 | gold quality |
| lymph node | UBERON:0000029 | 77.05 | gold quality |
| heart | UBERON:0000948 | 76.87 | gold quality |
| sperm | CL:0000019 | 76.36 | silver quality |
| cortical plate | UBERON:0005343 | 76.34 | gold quality |
| brain | UBERON:0000955 | 76.09 | gold quality |
| liver | UBERON:0002107 | 75.49 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 75.18 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.54 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- TLP-mediated global transcriptional repression after double-strand DNA breaks slows down DNA repair and induces apoptosis. (PMID:30890736)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | crip3 | ENSDARG00000043395 |
| mus_musculus | Crip3 | ENSMUSG00000023968 |
| rattus_norvegicus | Crip3 | ENSRNOG00000018613 |
Paralogs (20): FHL1 (ENSG00000022267), LMO3 (ENSG00000048540), LHX5 (ENSG00000089116), ZFHX4 (ENSG00000091656), LHX2 (ENSG00000106689), LHX6 (ENSG00000106852), LHX3 (ENSG00000107187), LHX4 (ENSG00000121454), LMO2 (ENSG00000135363), ZFHX2 (ENSG00000136367), LMX1B (ENSG00000136944), ZFHX3 (ENSG00000140836), LMO4 (ENSG00000143013), LHX9 (ENSG00000143355), LHX8 (ENSG00000162624), LMX1A (ENSG00000162761), LMO1 (ENSG00000166407), CRIP2 (ENSG00000182809), CRIP1 (ENSG00000213145), LHX1 (ENSG00000273706)
Protein
Protein identifiers
Cysteine-rich protein 3 — Q6Q6R5 (reviewed: Q6Q6R5)
Alternative names: Chromosome 6 LIM domain only protein
All UniProt accessions (3): Q6Q6R5, H0Y7Q9, Q5T045
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Cytoplasm.
Tissue specificity. Expressed in most tissues, but not in skeletal muscle.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6Q6R5-1 | 1, C | yes |
| Q6Q6R5-2 | 2, B | |
| Q6Q6R5-3 | 3, A | |
| Q6Q6R5-4 | 4, D |
RefSeq proteins (2): NP_001352997, NP_996805* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001781 | Znf_LIM | Domain |
Pfam: PF00412
UniProt features (9 total): splice variant 3, domain 2, sequence conflict 2, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6Q6R5-F1 | 74.81 | 0.42 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 44 (showing top):
GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_DN, STK33_SKM_DN, ZNF322_TARGET_GENES, MIR4731_5P, GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN, MIR423_5P, MIR3184_5P, MIR6759_3P, GSE12366_NAIVE_VS_MEMORY_BCELL_UP, MIR1911_5P, BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN, GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_UP, HAY_BONE_MARROW_DENDRITIC_CELL, GSE17721_POLYIC_VS_CPG_16H_BMDC_UP, WRNIP1_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (2): metal ion binding (GO:0046872), protein binding (GO:0005515)
GO Cellular Component (1): cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cation binding | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
284 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CRIP3 | TIRAP | P58753 | 576 |
| CRIP3 | HOXD8 | P13378 | 538 |
| CRIP3 | MYD88 | P78397 | 523 |
| CRIP3 | HOXD3 | P31249 | 521 |
| CRIP3 | HTRA1 | Q92743 | 479 |
| CRIP3 | SCO1 | O75880 | 467 |
| CRIP3 | TGFB2 | P08112 | 432 |
| CRIP3 | COA6 | Q5JTJ3 | 395 |
| CRIP3 | H0YIS7 | H0YIS7 | 393 |
| CRIP3 | TMEM128 | Q5BJH2 | 391 |
| CRIP3 | TMEM179 | Q6ZVK1 | 367 |
| CRIP3 | CIMIP2A | Q6J272 | 322 |
| CRIP3 | SARM1 | Q6SZW1 | 317 |
| CRIP3 | SH2D4B | Q5SQS7 | 316 |
| CRIP3 | OR2A7 | Q96R45 | 307 |
IntAct
1 interactions, top by confidence:
BioGRID (2): CRIP3 (Two-hybrid), FHL3 (Two-hybrid)
ESM2 similar proteins: A2YEZ6, A3BDI8, E0X9N4, O60711, O70209, O70400, O80839, P29675, P36201, P47226, P52943, P53777, Q0VFX8, Q16975, Q1LZA7, Q21192, Q24400, Q3EA33, Q3SX40, Q3SYZ8, Q3TJD7, Q4KM31, Q500W4, Q53GG5, Q5R7Y1, Q66HS7, Q679P3, Q6GLJ6, Q6INU3, Q6P7E4, Q6Q6R3, Q6Q6R5, Q6QGC0, Q7Y1W9, Q852K5, Q8BGB5, Q8H0X0, Q94JX5, Q99N69, Q9BIW5
Diamond homologs: A8DZE6, E1BKA3, F1MF74, F1QH17, F1QWK4, G3MWR8, O04193, O14014, O80839, P21291, P29675, P34416, P36201, P47875, P50238, P50460, P50461, P50462, P50463, P52943, P53410, P53777, P63254, P63255, P67966, P67967, P97314, P97315, Q04584, Q05158, Q0VFX8, Q13642, Q14192, Q16527, Q1ECF5, Q24400, Q2KI95, Q32LE9, Q3MHY1, Q4U0T9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
37 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 29 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2400 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:43299885:T:TA | acceptor_gain | 1.0000 |
| 6:43299890:T:A | acceptor_gain | 1.0000 |
| 6:43299891:G:A | acceptor_gain | 1.0000 |
| 6:43299896:A:AG | acceptor_gain | 1.0000 |
| 6:43299897:G:GG | acceptor_gain | 1.0000 |
| 6:43301690:GTG:G | donor_gain | 1.0000 |
| 6:43301698:G:GT | donor_gain | 1.0000 |
| 6:43302761:CAGGT:C | donor_loss | 1.0000 |
| 6:43302762:AGGT:A | donor_loss | 1.0000 |
| 6:43302763:GG:G | donor_loss | 1.0000 |
| 6:43302764:GTGA:G | donor_loss | 1.0000 |
| 6:43302765:T:G | donor_loss | 1.0000 |
| 6:43304669:A:AG | acceptor_gain | 1.0000 |
| 6:43304670:G:GG | acceptor_gain | 1.0000 |
| 6:43306123:TG:T | acceptor_gain | 1.0000 |
| 6:43306131:C:CT | acceptor_gain | 1.0000 |
| 6:43306314:C:CC | acceptor_gain | 1.0000 |
| 6:43307610:A:AC | donor_gain | 1.0000 |
| 6:43307611:C:CC | donor_gain | 1.0000 |
| 6:43307611:CTTTT:C | donor_gain | 1.0000 |
| 6:43308514:T:TA | donor_gain | 1.0000 |
| 6:43299894:CCA:C | acceptor_loss | 0.9900 |
| 6:43299895:CA:C | acceptor_loss | 0.9900 |
| 6:43299896:A:T | acceptor_loss | 0.9900 |
| 6:43299897:G:A | acceptor_loss | 0.9900 |
| 6:43299897:GA:G | acceptor_gain | 0.9900 |
| 6:43299897:GAGC:G | acceptor_gain | 0.9900 |
| 6:43299897:GAGCT:G | acceptor_gain | 0.9900 |
| 6:43299988:T:G | donor_gain | 0.9900 |
| 6:43300063:TCTGG:T | donor_loss | 0.9900 |
AlphaMissense
1340 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:43306454:A:T | V131D | 0.996 |
| 6:43306282:C:A | W144C | 0.995 |
| 6:43306282:C:G | W144C | 0.995 |
| 6:43306109:A:C | Y171D | 0.994 |
| 6:43306263:A:G | C151R | 0.994 |
| 6:43306476:A:G | C124R | 0.994 |
| 6:43306284:A:G | W144R | 0.993 |
| 6:43306284:A:T | W144R | 0.993 |
| 6:43307849:A:C | F62L | 0.993 |
| 6:43307849:A:T | F62L | 0.993 |
| 6:43307851:A:G | F62L | 0.993 |
| 6:43308378:C:A | W25C | 0.993 |
| 6:43308378:C:G | W25C | 0.993 |
| 6:43308380:A:G | W25R | 0.993 |
| 6:43308380:A:T | W25R | 0.993 |
| 6:43306077:A:C | F181L | 0.992 |
| 6:43306077:A:T | F181L | 0.992 |
| 6:43306079:A:G | F181L | 0.992 |
| 6:43306253:C:G | C154S | 0.992 |
| 6:43306254:A:T | C154S | 0.992 |
| 6:43306262:C:G | C151S | 0.992 |
| 6:43306263:A:T | C151S | 0.992 |
| 6:43306094:A:G | C176R | 0.991 |
| 6:43306104:G:C | C172W | 0.991 |
| 6:43306281:G:C | H145D | 0.991 |
| 6:43307881:A:C | Y52D | 0.991 |
| 6:43308359:A:G | C32R | 0.991 |
| 6:43306268:A:G | L149P | 0.990 |
| 6:43306279:G:C | H145Q | 0.990 |
| 6:43306279:G:T | H145Q | 0.990 |
dbSNP variants (sampled 300 via entrez): RS1002130301 (6:43306679 T>C), RS1002162974 (6:43306956 C>T), RS1002798038 (6:43309582 G>A), RS1002870266 (6:43309870 A>T), RS1003203414 (6:43308489 G>A), RS1004761361 (6:43306088 C>A,T), RS1004788366 (6:43309065 C>T), RS1004827097 (6:43310330 T>C), RS1005178609 (6:43305268 A>G), RS1005250663 (6:43305540 C>A), RS1005501185 (6:43310324 C>A,T), RS1006728651 (6:43305759 A>G,T), RS1007581094 (6:43308528 G>A,C), RS1008585250 (6:43306831 G>GCCA), RS1008846918 (6:43307235 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
20 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004521_164 | Autism spectrum disorder or schizophrenia | 3.000000e-08 |
| GCST005956_58 | Waist-to-hip ratio adjusted for BMI | 7.000000e-26 |
| GCST005957_1 | Waist-to-hip ratio adjusted for BMI (age <50) | 2.000000e-14 |
| GCST005958_2 | Waist-to-hip ratio adjusted for BMI (age >50) | 2.000000e-19 |
| GCST005962_2 | Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) | 3.000000e-31 |
| GCST006187_17 | Diastolic blood pressure (cigarette smoking interaction) | 1.000000e-10 |
| GCST006188_32 | Systolic blood pressure (cigarette smoking interaction) | 8.000000e-21 |
| GCST007096_193 | Pulse pressure | 3.000000e-06 |
| GCST007099_135 | Systolic blood pressure | 1.000000e-09 |
| GCST007703_139 | Systolic blood pressure | 4.000000e-10 |
| GCST007704_105 | Diastolic blood pressure | 1.000000e-06 |
| GCST007705_69 | Pulse pressure | 4.000000e-06 |
| GCST007706_92 | Mean arterial pressure | 4.000000e-09 |
| GCST007707_66 | Hypertension | 1.000000e-06 |
| GCST008058_90 | Estimated glomerular filtration rate | 1.000000e-20 |
| GCST008059_82 | Estimated glomerular filtration rate | 2.000000e-20 |
| GCST008839_248 | Height | 4.000000e-08 |
| GCST008899_1 | Adult hearing difficulty | 6.000000e-21 |
| GCST012227_9 | Hip circumference adjusted for BMI | 2.000000e-08 |
| GCST012442_37 | Age-related hearing impairment | 1.000000e-17 |
EFO canonical traits (9, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0008007 | age at assessment |
| EFO:0008343 | sex interaction measurement |
| EFO:0006336 | diastolic blood pressure |
| EFO:0006527 | smoking status measurement |
| EFO:0006335 | systolic blood pressure |
| EFO:0005763 | pulse pressure measurement |
| EFO:0006340 | mean arterial pressure |
| EFO:0008039 | BMI-adjusted hip circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
26 total (human), top 26 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases methylation, decreases expression | 2 |
| Aflatoxin B1 | decreases expression | 2 |
| propionaldehyde | increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| pentanal | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| abrine | decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| N-Nitrosopyrrolidine | decreases expression | 1 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | affects expression | 1 |
| Cyclosporine | decreases methylation | 1 |
| Okadaic Acid | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): hypertensive disorder, presbycusis